22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January

22nd Century Group, Inc. (NASDAQ:XXII) was the target of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 178,800 shares, a decrease of 63.8% from the January 15th total of 493,400 shares. Currently, 11.5% of the company’s shares are short sold. Based on an average daily volume of 875,300 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Investors Weigh In On 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new stake in 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is owned by institutional investors and hedge funds.

22nd Century Group Trading Up 2.6 %

XXII stock traded up $0.09 during mid-day trading on Wednesday, reaching $3.31. The company’s stock had a trading volume of 19,350 shares, compared to its average volume of 1,911,161. 22nd Century Group has a 12 month low of $3.04 and a 12 month high of $581.85. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59. The business’s 50 day moving average price is $6.00 and its 200 day moving average price is $26.82. The company has a market cap of $5.68 million, a price-to-earnings ratio of 0.00 and a beta of 1.57.

22nd Century Group (NASDAQ:XXII) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. The firm had revenue of $5.95 million for the quarter.

Analyst Upgrades and Downgrades

XXII has been the topic of a number of recent analyst reports. Weiss Ratings restated a “sell (e)” rating on shares of 22nd Century Group in a research report on Saturday, February 1st. StockNews.com cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Tuesday, December 31st.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.